You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,703,806


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,703,806
Title:Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
Abstract: Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium.
Inventor(s): Vehring; Reinhard (Edmonton, CA), Hartman; Michael Steven (Millbrae, CA), Lechuga-Ballesteros; David (San Jose, CA), Smith; Adrian Edward (Emerald Hills, CA), Joshi; Vidya B. (Redwood City, CA), Dwivedi; Sarvajna Jumar (Redwood City, CA)
Assignee: Pearl Therapeutics, Inc. (Redwood City, CA)
Application Number:13/692,904
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,703,806: A Comprehensive Analysis

Introduction

United States Patent 8,703,806, like any other patent, is a complex document that outlines the invention, its scope, and the claims that define the intellectual property protected by the patent. This article will delve into the key aspects of this patent, including its background, the invention itself, the claims, and the broader patent landscape.

Background of the Patent

To understand the patent, it is crucial to start with its background. This includes the inventors, the assignees, the filing and grant dates, and any relevant prior art or related patents. The patent in question would typically be part of a larger family of patents, each with its own specific claims and scope.

The Invention

Overview

The invention described in United States Patent 8,703,806 would be detailed in the specification section of the patent. This section explains the problem the invention solves, the prior art, and how the invention differs from existing solutions. It also includes detailed descriptions and drawings that illustrate the invention.

Technical Field

The technical field of the invention is critical in understanding its scope. For example, if the patent pertains to pharmaceutical compositions, it would involve detailed descriptions of the chemical compounds, their synthesis, and their application[5].

Claims

Importance of Claims

The claims section of a patent is the most critical part as it defines the scope of the invention and what is protected by the patent. Claims are typically divided into independent and dependent claims.

Independent Claims

Independent claims stand alone and define the broadest scope of the invention. They are usually more general and encompass the core aspects of the invention.

Dependent Claims

Dependent claims build upon the independent claims and add specific limitations or features. These claims are narrower and provide additional details about the invention.

Claim Construction

Claim construction is the process of interpreting the meaning and scope of the claims. This is often a point of contention in patent litigation and involves analyzing the language of the claims, the specification, and any relevant prosecution history.

Patent Landscape

Related Patents

Understanding the patent landscape involves identifying related patents, including continuations, continuations-in-part, and divisional patents. For instance, in the case of In re Cellect, multiple patents were part of a family and were subject to obviousness-type double patenting (ODP) analysis[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This is particularly relevant when patents in the same family have different expiration dates due to Patent Term Adjustments (PTA)[1].

Patent Term Adjustments (PTA)

PTA is a mechanism to adjust the term of a patent to account for delays during the prosecution process. However, as seen in In re Cellect, PTA does not extend the term of a patent past the date of a terminal disclaimer, which is often used to overcome ODP rejections[1].

Prosecution History

The prosecution history of a patent, including any office actions, responses, and amendments, provides valuable context for understanding the claims and their scope. This history can be crucial in determining the intent of the inventors and the examiner during the patent application process.

Litigation and Enforcement

Patents are often the subject of litigation, particularly when there are disputes over infringement or validity. Understanding the litigation history of a patent and its family can provide insights into how the claims have been interpreted and enforced.

Economic Impact

The economic impact of a patent can be significant, influencing innovation, competition, and market dynamics. The USPTO's economic research datasets can provide insights into the economic effects of patents, including their scope and claims[3].

Industry Expert Insights

Industry experts often provide valuable perspectives on the significance and impact of a patent. For example, in the pharmaceutical industry, a patent like US-2003114428-A1 for asthma treatments would be analyzed for its therapeutic benefits, market potential, and competitive landscape[5].

Statistics and Trends

Analyzing statistical data on patents can reveal trends and patterns. For instance, data from the USPTO or the National Science Foundation can show the number of patents granted in specific technical fields over time, which can help in understanding the broader patent landscape[4].

Key Takeaways

  • Claims Definition: The claims section is the heart of a patent, defining what is protected.
  • Patent Landscape: Understanding related patents and the broader landscape is crucial.
  • ODP and PTA: These concepts are vital in managing patent families and ensuring compliance.
  • Prosecution History: This history provides context for claim interpretation.
  • Economic Impact: Patents have significant economic implications.
  • Industry Insights: Experts can offer valuable perspectives on a patent's significance.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the scope of the invention and what is protected by the patent.

How does Obviousness-Type Double Patenting (ODP) affect patent families?

ODP prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent, ensuring that patents in the same family do not extend beyond the original expiration date.

What is Patent Term Adjustment (PTA), and how does it impact patents?

PTA adjusts the term of a patent to account for delays during the prosecution process, but it does not extend the term past the date of a terminal disclaimer.

Why is the prosecution history of a patent important?

The prosecution history provides valuable context for understanding the claims and their scope, including any interactions between the inventors and the examiner.

How can statistical data on patents help in understanding the patent landscape?

Statistical data can reveal trends and patterns in patent filings and grants, helping to understand the broader patent landscape and the impact of patents in specific technical fields.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. U.S. Patent and Trademark Office (USPTO) - USAGov[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Invention, Knowledge Transfer, and Innovation - National Science Foundation[4].
  5. Pharmaceutical compositions for the treatment of asthma - PubChem[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,703,806

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astrazeneca BEVESPI AEROSPHERE formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 208294-001 Apr 25, 2016 RX Yes Yes 8,703,806 ⤷  Subscribe USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ⤷  Subscribe
Astrazeneca Ab BREZTRI AEROSPHERE budesonide; formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 212122-001 Jul 23, 2020 RX Yes Yes 8,703,806 ⤷  Subscribe USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,703,806

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2435025 ⤷  Subscribe 300995 Netherlands ⤷  Subscribe
European Patent Office 2435025 ⤷  Subscribe PA2019014 Lithuania ⤷  Subscribe
European Patent Office 2435025 ⤷  Subscribe 122019000068 Germany ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.